Evidence map›Paper›PMID 34579195›Full record

ReviewVaccines2021

Interests of the Non-Human Primate Models for HIV Cure Research.

Gauthier Terrade, Nicolas Huot, Caroline Petitdemange, Marie Lazzerini, Aurelio Orta Resendiz, Beatrice Jacquelin, Michaela Müller-Trutwin

Open access · goldAbstract readReview
In one paragraph

Review in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. HIV Latency in Myeloid Cells: Challenges for a Cure.Pathogens (Basel, Switzerland) · 2022
    Review
  14. Article
  15. FoxP3Frontiers in immunology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gauthier TerradeInstitut Pasteur, Unité HIV, Inflammation et Persistance, 75015 Paris, France.
Nicolas HuotInstitut Pasteur, Unité HIV, Inflammation et Persistance, 75015 Paris, France.
Caroline PetitdemangeInstitut Pasteur, Unité HIV, Inflammation et Persistance, 75015 Paris, France.
Marie LazzeriniInstitut Pasteur, Unité HIV, Inflammation et Persistance, 75015 Paris, France.
Aurelio Orta ResendizInstitut Pasteur, Unité HIV, Inflammation et Persistance, 75015 Paris, France.ORCID 0000-0002-6632-883X
Beatrice JacquelinInstitut Pasteur, Unité HIV, Inflammation et Persistance, 75015 Paris, France.
Michaela Müller-TrutwinInstitut Pasteur, Unité HIV, Inflammation et Persistance, 75015 Paris, France.ORCID 0000-0002-3854-2396
Institut Pasteur · FR

Funding

Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid FolliclesR01AI143457 · NIAID · DUKE UNIVERSITY · PI REEVES, ROGER KEITH · 2019 to 2023
$3.1M
NIAID NIH HHS R01 AI143457
6 · The paper itself

Abstract

Non-human primate (NHP) models are important for vaccine development and also contribute to HIV cure research. Although none of the animal models are perfect, NHPs enable the exploration of important questions about tissue viral reservoirs and the development of intervention strategies. In this review, we describe recent advances in the use of these models for HIV cure research and highlight the progress that has been made as well as limitations using these models. The main NHP models used are (i) the macaque, in which simian immunodeficiency virus (SIVmac) infection displays similar replication profiles as to HIV in humans, and (ii) the macaque infected by a recombinant virus (SHIV) consisting of SIVmac expressing the HIV envelope gene serving for studies analyzing the impact of anti-HIV Env broadly neutralizing antibodies. Lessons for HIV cure that can be learned from studying the natural host of SIV are also presented here. An overview of the most promising and less well explored HIV cure strategies tested in NHP models will be given.

Indexed as

animal modelcureHIVimmunitynatural hostnon-human primateSIVtherapies

Identifiers

PMID34579195
PMCPMC8472852
OpenAlexW3197782302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.